Belite Bio (BLTE) Non-Current Assets (2021 - 2026)

Belite Bio's Non-Current Assets history runs 6 years deep, the most recent figure standing at $289.4 million for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 5789.44% year-over-year to $289.4 million in Q1 2026; TTM through Mar 2026 was $304.9 million, a 1529.12% increase from a year earlier, with the FY2025 full-year figure at $286.3 million, up 5558.9% from the prior year.
• Non-Current Assets improved to $289.4 million in Q1 2026 per BLTE's latest filing, from $286.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $289.4 million in Q1 2026 and bottomed at $1.4 million in Q1 2023.
• The 5-year median for Non-Current Assets is $4.7 million (2023), against an average of $44.3 million.
• Across the five-year window, Non-Current Assets grew 5.02% in 2025 and surged 5789.44% in 2026, its largest moves.
• Year by year, Non-Current Assets stood at $1.5 million in 2022, then jumped by 220.74% to $4.7 million in 2023, then grew by 7.59% to $5.1 million in 2024, then surged by 5558.9% to $286.3 million in 2025, then advanced by 1.09% to $289.4 million in 2026.
• Per Business Quant, the three latest BLTE Non-Current Assets figures stand at $289.4 million (Q1 2026), $286.3 million (Q4 2025), and $5.2 million (Q3 2025).